Sound Medicine – Avastin’s Benefits Overstated for Breast Cancer

Sound Medicine is a radio show produced by the Indiana University School of Medicine and WFYI Public Radio. In the last few years, I’ve become their go-to guy on health policy. So, for those of you who would find your day brightened by the sound of my voice, enjoy the following.

Indiana University health care policy expert Aaron Carroll, MD, weighs in on the debate over FDA approval of Avastin for late-stage cancer patients.

He views the drug as minimally effective, a cause of serious side effects, and too expensive to warrant its use for late-stage breast cancer patients.

Audio after the jump.

Hidden information below


Email Address*